From Our Desks

From Our Desks

Newsletter Summer 2020 - From Kinexum Founder, Zan Fleming

Newsletter Summer 2020 - A Note from the CEO, Thomas Seoh

Newsletter Summer 2020 - Brian Harvey, NASH Development Update—Summer 2020

Newsletter Summer 2020 - Dimitri Stephanou, Balancing Strategy, Agility, and Innovative Transformation in Achieving Operational Excellence

Newsletter Summer 2020 - Adriane Berg, Aging at the Tipping Point:

Newsletter Summer 2020 - Shana Azri-Meehan, Preclinical Considerations for the Development of New Antibiotics

Newsletter Summer 2020 - Jennifer Zhao, The Next Generation

Newsletter Spring 2020 From Kinexum Founder, Zan Fleming

Newsletter Spring 2020 Note from CEO, Thomas Seoh

Newsletter Spring 2020 NASH Update—March 2020 by Brian Harvey

Newsletter Spring 2020 Potomac Fever and a Life of Stories by Steven Grossman

Newsletter Spring 2020 THE TARGET PRODUCT PROFILE by Albert Yehaskel

Newsletter Spring 2020 Wow or Yeow!? FDA's 2019 Review and 2020 Outlook Webinar Highlights by Jennifer Zhao

Newsletter Winter 2020 - James Carroll_Why Photobiomodulation Might be the Answer to the Opioid Crisis

Newsletter Winter 2020 note from the CEO

Newsletter Winter 2020 - Thomas Seoh Another Immigrant’s Tale

Newsletter Winter 2020 - Michael Zemel_Reflections on Targeting Metabesity 2019

Newsletter Winter 2020 - Founder, Dr. Zan Fleming

Newsletter Winter 2020 - Faiez Zannad_Interview with Professor Faiez Zannad on the Cardiovascular Clinical Trialists Forum (CVCT)

Newsletter Fall 2019 - Founder, Dr. Zan Fleming

Newsletter Fall 2019 note from the CEO

Newsletter Fall 2019 - M Prasad Palthur, Ph.D. - Artificial Pancreas Device Systems (ADPS) – Directions for Future Developmentt

Newsletter Fall 2019 - Mustafa Noor, MD - My Journey as a Recently Arrived Refugee to America

Newsletter Summer 2019 - Webcast Recap: Dr. Ralph DeFronzo on Type 2 Diabetes

Newsletter Summer 2019 - Alan Fisher, Experiences as a Data Monitoring Committee Biostatistician

Newsletter Summer 2019 - M Prasad Palthur, Artificial Pancreas Device Systems (ADPS) – General Product Development and Regulatory Pathways

Newsletter Summer 2019 - Bill Hoover, Issues with Product Development Traceability

Newsletter Summer 2019 - CEO, Thomas Seoh

Newsletter Summer 2019 - Founder, Dr. Zan Fleming

Newsletter Summer 2019 - George Baeder - How China is Changing the Clinical Development Landscape 

Newsletter Spring 2019 - Founder, Dr. Zan Fleming

Newsletter Spring 2019 - note from the CEO Thomas Seoh

Newsletter Spring 2019 - John Kucharczyk, Can Blockchain and Artificial Intelligence Transform the Management of Healthcare?

Newsletter Spring 2019 - Brian Oscherwitz, Perspective on How the Kinexum Advantage Benefits Its Consultants and Clients

Newsletter Spring 2019 - Jennifer Zhao, Perspectives as a Kinexum Associate  

Newsletter Spring 2019 - Prasad Palthur, Artificial Pancreas Device Systems – An Evolving Approach and Research Pathway

Newsletter Winter 2019 - Tom Hedberg The Silent Epidemic of Diabetes in china

Newsletter Winter 2019 - David Bergstrom - Strategies to Approaching CMC New Product Development and Manufacturing Outsourcing Resources

Newsletter Winter 2019 - Michael Cobb - Applications of Machine LEarning in Healthcare: Scalable Treatment Solutions for Cancer Patients

Newsletter Winter 2019 - Susan Manley - Early NDA Planning for Small to Mid-sized Companies

Newsletter Winter 2019 From Kinexum Founder: Staying on the NDA Learning Curve

Newsletter Winter 2019 - Note from the CEO

Newsletter Winter 2019 - Jennifer Zhao, Kinexum Webcast Recap: Using Metformin to Target Aging

 

Newsletter Archives